The Future of ADC Manufacturing
Antibody-drug conjugates (ADCs) are an advanced cancer therapy designed to precisely target and deliver cytotoxic agents directly to cancer cells. However, this approach introduces significant challenges in manufacturing, particularly in safely handling highly potent cytotoxic payloads. As the number of ADC candidates rises and regulatory safety standards become more stringent, the complexities of ADC manufacturing […]